Cytokine gene polymorphism in human disease: on-line databases, Supplement 2

[1]  J. Mansfield,et al.  Role of Polymorphisms in the Interleukin-10 Gene in Determining Disease Susceptibility and Phenotype in Inflamatory Bowel Disease , 2001, Digestive Diseases and Sciences.

[2]  T. Sharma,et al.  Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. , 2001, Diabetes research and clinical practice.

[3]  A. Kastrati,et al.  Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. , 2001, Atherosclerosis.

[4]  M. Aidoo,et al.  Tumor necrosis factor‐α promoter variant 2 (TNF2) is associated with pre‐term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX , 2001, Genetic epidemiology.

[5]  N. Anthonisen,et al.  Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers , 2001, Thorax.

[6]  L. Newman,et al.  High Beryllium-stimulated TNF- α Is Associated with the − 308 TNF- α Promoter Polymorphism and with Clinical Severity in Chronic Beryllium Disease , 2001 .

[7]  F. Wiklund,et al.  Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. , 2001, Human immunology.

[8]  W. Ollier,et al.  Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. , 2001, Arthritis and rheumatism.

[9]  Y. Akai,et al.  Association of transforming growth factor-β1 T29C polymorphism with the progression of diabetic nephropathy , 2001 .

[10]  C. Lam,et al.  A polymorphism in the coding region of interleukin‐13 gene is associated with atopy but not asthma in Chinese children , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Y. Choi,et al.  Tumor necrosis factor receptor 2 polymorphism in systemic lupus erythematosus: no association with disease. , 2001, Human immunology.

[12]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[13]  A. Cox,et al.  The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. , 2001, Gastroenterology.

[14]  M. Onda,et al.  Association of the interleukin-1 β genetic polymorphism and gastric cancer risk in Japanese , 2001, Journal of Gastroenterology.

[15]  R. Kaji,et al.  Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease , 2001, Neuroscience Letters.

[16]  M. Hurme,et al.  Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. , 2001, The Journal of infectious diseases.

[17]  A. Alcina,et al.  The −174/−597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis , 2001, Journal of the Neurological Sciences.

[18]  M. Arca,et al.  The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution , 2001, BMC Medical Genetics.

[19]  Lee Yj,et al.  Association between TNF-α promoter polymorphism and Helicobacter pylori cagA subtype infection , 2001 .

[20]  A. Dickinson,et al.  Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. , 2001, Blood.

[21]  Á. Lanas,et al.  The polymorphic IL‐1B and IL‐1RN genes in the aetiopathogenesis of peptic ulcer , 2001, Clinical and experimental immunology.

[22]  K. Tokunaga,et al.  Lack of association of -308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. , 2001, American journal of medical genetics.

[23]  J. Bernstein,et al.  Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. , 2001, Clinical immunology.

[24]  N. Camp,et al.  Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty , 2001, Heart.

[25]  K. Elliott,et al.  The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. , 2001, The Journal of allergy and clinical immunology.

[26]  F. Wollheim,et al.  Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis , 2001, Annals of the rheumatic diseases.

[27]  C. Schneeberger,et al.  A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage. , 2001, Fertility and sterility.

[28]  C. Lewis,et al.  A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo , 2001, The British journal of dermatology.

[29]  J. Peltola,et al.  Polymorphism of the interleukin‐1 gene complex in localization‐related epilepsy , 2001, Annals of neurology.

[30]  U Hegerl,et al.  Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. , 2001, The American journal of psychiatry.

[31]  J. Chase,et al.  Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. , 2001, The Journal of allergy and clinical immunology.

[32]  B. Anlar,et al.  Tumor Necrosis Factor-Alpha Gene Polymorphisms in Children with Multiple Sclerosis , 2001, Neuropediatrics.

[33]  S. Eyre,et al.  Two novel polymorphisms in the human transforming growth factor beta 2 gene , 2001, Genes and Immunity.

[34]  C. Folwaczny,et al.  Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases , 2001, Genes and Immunity.

[35]  K. Sullivan,et al.  Interferon-γ polymorphisms in systemic lupus erythematosus , 2001, Genes and Immunity.

[36]  D. Metcalfe,et al.  Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin. , 2001, Blood.

[37]  K. Boberg,et al.  Association of the tumour necrosis factor á − 308 but not the interleukin 10 − 627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis , 2001 .

[38]  F. McQueen,et al.  Interferon-gamma microsatellite and rheumatoid arthritis , 2001, The Lancet.

[39]  R. Kaji,et al.  Influence of interleukin-1β gene polymorphism on age-at-onset of spinocerebellar ataxia 6 (SCA6) in Japanese patients , 2001, Neuroscience Letters.

[40]  S. Witkin,et al.  Interleukin-1 Receptor Antagonist Gene Polymorphism and Circulating Levels of Human Immunodeficiency Virus Type 1 RNA in Brazilian Women , 2001, Journal of Virology.

[41]  A. Koivisto,et al.  Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  J. Graff,et al.  Transforming Growth Factor-β Receptor Type I Gene Is Frequently Mutated in Ovarian Carcinomas , 2001 .

[43]  L. N. Valenti,et al.  Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. , 2001, Blood.

[44]  E. Ziv,et al.  Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. , 2001, JAMA.

[45]  H. Harbo,et al.  Analysis of an interferon-γ gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients , 2001 .

[46]  M. Sperling,et al.  Lack of Association Between an Interleukin 1 Beta (IL‐1β) Gene Variation and Refractory Temporal Lobe Epilepsy , 2001 .

[47]  P. Rieckmann,et al.  Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promoter region in families with localized early-onset periodontitis. , 2001, Journal of Periodontal Research.

[48]  Yoshiji Yamada,et al.  Association Between a Polymorphism of the Transforming Growth Factor-&bgr;1 Gene and Genetic Susceptibility to Ossification of the Posterior Longitudinal Ligament in Japanese Patients , 2001, Spine.

[49]  T. Huizinga,et al.  Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. , 2001, Cytokine.

[50]  B. Griffith,et al.  The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[51]  C. López-Larrea,et al.  TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. , 2001, The Journal of rheumatology.

[52]  A. Pasternack,et al.  Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. , 2001, Rheumatology.

[53]  G. H. Jackson,et al.  Donor interleukin 1 receptor antagonist genotype associated with acute graft‐versus‐host disease in human leucocyte antigen‐matched sibling allogeneic transplants , 2001, British journal of haematology.

[54]  S. Steinberg,et al.  Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study , 2001, British journal of haematology.

[55]  M. Yamauchi,et al.  Polymorphism of tumor necrosis factor-beta and alcohol dehydrogenase genes and alcoholic brain atrophy in Japanese patients. , 2001, Alcoholism, clinical and experimental research.

[56]  P. Miossec,et al.  IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels , 2001, Genes and Immunity.

[57]  M. Shaw,et al.  Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes , 2001, Genes and Immunity.

[58]  K. Asadullah,et al.  Interleukin-10 promoter polymorphism in psoriasis. , 2001, The Journal of investigative dermatology.

[59]  E. El-Omar.  The importance of interleukin 1β inHelicobacter pylori associated disease , 2001, Gut.

[60]  P. Kremsner,et al.  Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene , 2001, Genes and Immunity.

[61]  J. Mužík,et al.  Duration of Non-Insulin-Dependent Diabetes mellitus and the TNF-β NcoI Genotype as Predictive Factors in Proliferative Diabetic Retinopathy , 2001, Ophthalmologica.

[62]  W. Weimar,et al.  THE TRANSFORMING GROWTH FACTOR-&bgr;1 CODON 10 GENE POLYMORPHISM AND ACCELERATED GRAFT VASCULAR DISEASE AFTER CLINICAL HEART TRANSPLANTATION , 2001, Transplantation.

[63]  T. Klein,et al.  ROLE OF CYTOKINE GENE POLYMORPHISM IN HEPATITIS C RECURRENCE AND ALLOGRAFT REJECTION AMONG LIVER TRANSPLANT RECIPIENTS 1 , 2001, Transplantation.

[64]  J. Chun,et al.  The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. , 2001, Cancer letters.

[65]  L. Harrell,et al.  Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. , 2001, American journal of medical genetics.

[66]  J. Powell,et al.  Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms , 2001, Circulation.

[67]  K. Welsh,et al.  Analysis of Tumor Necrosis Factor- α , Lymphotoxin- α , Tumor Necrosis Factor Receptor II, and Interleukin-6 Polymorphisms in Patients with Idiopathic Pulmonary Fibrosis , 2001 .

[68]  P. Galle,et al.  IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. , 2001, Arthritis and rheumatism.

[69]  M. Tomonaga,et al.  Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. , 2001, Cancer research.

[70]  K. Fearon,et al.  Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. , 2001, Surgery.

[71]  P. Papapanou,et al.  Interleukin-1 gene polymorphism and periodontal status. A case-control study. , 2001, Journal of clinical periodontology.

[72]  S. Khoo,et al.  Novel IFN-α receptor promoter polymorphisms , 2001, Genes and Immunity.

[73]  J. Haines,et al.  Sequence variation in the transforming growth factor-β1 (TGFB1) gene and multiple sclerosis susceptibility , 2001, Journal of Neuroimmunology.

[74]  K. Deichmann,et al.  A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor α-chain gene is associated with decreased soluble interleukin-4 receptor protein levels , 2001, Immunogenetics.

[75]  F. Breedveld,et al.  Allele-specific quantification of tumor necrosis factor α (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals , 2001, Genes and Immunity.

[76]  M. Pirmohamed,et al.  TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients , 2001, Neurology.

[77]  M. Hurme,et al.  The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. , 2001, European cytokine network.

[78]  P. Thomas.  Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma , 2001 .

[79]  Identification of four novel dinucleotide repeat polymorphisms in the IL-2 and IL-2beta receptor genes. , 2001, Human immunology.

[80]  C. Schneeberger,et al.  Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. , 2001, Fertility and sterility.

[81]  T. Lehtimäki,et al.  A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis , 2001, Journal of the Neurological Sciences.

[82]  G. Assmann,et al.  Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus. , 2001, Rheumatology.

[83]  K. Matsuo,et al.  Interleukin 1 Polymorphisms, Lifestyle Factors, and Helicobacter pylori Infection , 2001, Japanese journal of cancer research : Gann.

[84]  K. Tokunaga,et al.  Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter , 2001, Genes and Immunity.

[85]  E. Brand,et al.  Tumor necrosis factor-α−308 G/A polymorphism in obese Caucasians , 2001, International Journal of Obesity.

[86]  B. Morris,et al.  Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease , 2001, Journal of Molecular Medicine.

[87]  Yoshiji Yamada,et al.  Association of the C–509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women , 2001, Journal of Molecular Medicine.

[88]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases, Supplement 1 , 2001, Genes and Immunity.

[89]  R. Westendorp,et al.  Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[90]  K. Ihara,et al.  Association of IFN-γ and IFN regulatory factor 1 polymorphisms with childhood atopic asthma , 2001 .

[91]  Y. Kawakami,et al.  The Gene Polymorphism of Tumor Necrosis Factor-β, But Not That of Tumor Necrosis Factor-α, Is Associated With the Prognosis of Sarcoidosis , 2001 .

[92]  Y. Ohnishi,et al.  Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. , 2001, American journal of human genetics.

[93]  D S Sharp,et al.  Polymorphisms of the IL-1 gene complex in coal miners with silicosis. , 2001, American journal of industrial medicine.

[94]  P. Howarth,et al.  Invited Lecture: Activation of the Epithelial Mesenchymal Trophic Unit in the Pathogenesis of Asthma , 2001, International Archives of Allergy and Immunology.

[95]  M. Arman,et al.  Identification of a novel single-nucleotide polymorphism (Val554Ile) and definition of eight common alleles for human IL4RA exon 11. , 2001, Tissue antigens.

[96]  N. Becker,et al.  Cross-sectional study on cytokine polymorphisms, cytokine production after T-cell stimulation and clinical parameters in a random sample of a German population , 2001, Human Genetics.

[97]  M. Perola,et al.  Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. , 2001, Atherosclerosis.

[98]  S. Remadi,et al.  Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. , 2001, Cancer.

[99]  D. Middleton,et al.  Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia: a case-control study , 2001, The Lancet.

[100]  P. Mercier,et al.  TNF-α and IL-6 gene polymorphism and rejection in kidney transplantation recipients , 2001 .

[101]  H. Shirasawa,et al.  Association of tumor necrosis factor α gene promoter polymorphism with the presence of chronic obstructive pulmonary disease , 2001 .

[102]  R. Vaughan,et al.  Plasma Tumor Necrosis Factor α Levels and the –238* A Promoter Polymorphism in Patients with Antiphospholipid Syndrome , 2001, Thrombosis and Haemostasis.

[103]  P. Hasleton,et al.  A single nucleotide polymorphism at position --109 of the RANTES proximal promoter. , 2001, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[104]  T. Laitinen,et al.  The functionally important IL-10 promoter polymorphism (-1082G-->A) is not a major genetic regulator in recurrent spontaneous abortions. , 2001, Molecular human reproduction.

[105]  S. Marshall,et al.  DONOR CYTOKINE GENOTYPE INFLUENCES THE DEVELOPMENT OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION , 2001, Transplantation.

[106]  P. R. Evans,et al.  Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. , 2001, Transplant immunology.

[107]  P. Zabel,et al.  Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. , 2001, American journal of respiratory and critical care medicine.

[108]  A. Demaine,et al.  A study of cytokine gene polymorphisms and protein secretion in renal transplantation. , 2001, Transplant immunology.

[109]  A. Bateman,et al.  IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma , 2001, Genes and Immunity.

[110]  M. Hudson,et al.  Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn’s disease in a British population , 2001, Genes and Immunity.

[111]  E. Sampaio,et al.  Tumor necrosis factor-α promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensivity reaction in the skin of borderline tuberculoid leprosy patients , 2001, Immunogenetics.

[112]  D. Arveiler,et al.  New polymorphisms in the interleukin‐10 gene – relationships to myocardial infarction , 2001, European journal of clinical investigation.

[113]  S. Duffy,et al.  The Carriage of Pro‐Inflammatory Cytokine Gene Polymorphisms in Recurrent Pregnancy Loss , 2001, American journal of reproductive immunology.

[114]  C. Folwaczny,et al.  The polymorphism at position −174 of the IL-6 gene is not associated with inflammatory bowel disease , 2001, European journal of gastroenterology & hepatology.

[115]  V. Giedraitis,et al.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation , 2001, Journal of Neuroimmunology.

[116]  Andreas Radbruch,et al.  Low T cell production of TNFα and IFNγ in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism , 2001 .

[117]  齋藤 理.  Polymorphism of tumor necrosis factor in esophageal, gastric or colorectal carcinoma , 2001 .

[118]  E. Bröcker,et al.  Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. , 2001, Acta dermato-venereologica.

[119]  R. Cantor,et al.  Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. , 2001, American journal of respiratory and critical care medicine.

[120]  D. Middleton,et al.  Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. , 2001, Lancet.

[121]  Andreas Radbruch,et al.  Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. , 2001, Annals of the Rheumatic Diseases.

[122]  H. Harbo,et al.  Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients. , 2001, Multiple sclerosis.

[123]  E. Génin,et al.  Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. , 2001, Cytokine.

[124]  M. Sperling,et al.  Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. , 2001, Epilepsia.

[125]  N. Hizawa,et al.  The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. , 2001, Chest.

[126]  P. Mercier,et al.  TNF-alpha and IL-6 gene polymorphism and rejection in kidney transplantation recipients. , 2001, Transplantation proceedings.

[127]  P. Thomas.  Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. , 2001, Immunology and cell biology.

[128]  S. Humphries,et al.  A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. , 2001, Arthritis and rheumatism.

[129]  S. Teramoto,et al.  No association of tumor necrosis factor-alpha gene polymorphism and copd in Caucasian smokers and Japanese smokers. , 2001, Chest.

[130]  K. Welsh,et al.  Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[131]  A. Silman,et al.  Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. , 2001, Arthritis and rheumatism.

[132]  A. Pasternack,et al.  Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. , 2001, Arthritis and rheumatism.

[133]  K. Ihara,et al.  Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. , 2001, The Journal of allergy and clinical immunology.

[134]  K. Sullivan,et al.  Interferon-gamma polymorphisms in systemic lupus erythematosus. , 2001, Genes and immunity.

[135]  H. Shirasawa,et al.  Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[136]  H. Hashimoto,et al.  Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese. , 2001, Tissue antigens.

[137]  E. Brand,et al.  Tumor necrosis factor-alpha--308 G/A polymorphism in obese Caucasians. , 2001, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[138]  H. Marshall.  RANTES polymorphism affects susceptibility to HIV and asthma. , 2001, Trends in immunology.

[139]  L. Newman,et al.  High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. , 2001, American journal of respiratory and critical care medicine.

[140]  H. E. Marshall.  Anti B cell therapy proves successful in severe cases of rheumatoid arthritis. , 2001, Trends in immunology.

[141]  M. Emi,et al.  Five novel single-nucleotide polymorphisms of human interferon gamma identified by sequencing the entire gene , 2001, Journal of Human Genetics.

[142]  Y. J. Lee,et al.  Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. , 2001, Journal of clinical pathology.

[143]  R. Pioli,et al.  Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia , 2001, Molecular Psychiatry.

[144]  M. Albert,et al.  Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. , 2000, American journal of medical genetics.

[145]  P. Hayes,et al.  Polymorphisms in tumour necrosis factor α, interleukin-10 and transforming growth factor β1 genes and end-stage liver disease , 2000 .

[146]  A. Hajeer,et al.  Association of IL-10 genotype with sudden infant death syndrome. , 2000, Human immunology.

[147]  E. Sampaio,et al.  Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha. , 2000, Leprosy review.

[148]  M. Matsuoka,et al.  Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. , 2000, Human immunology.

[149]  R. Detels,et al.  Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study , 2000, AIDS.

[150]  P. Hayes,et al.  Polymorphisms in tumour necrosis factor &agr;, interleukin‐10 and transforming growth factor &bgr;1 genes and end‐stage liver disease , 2000, European journal of gastroenterology & hepatology.

[151]  N. Craddock,et al.  Tumour necrosis factor alpha and bipolar affective puerperal psychosis. , 2000, Psychiatric genetics.

[152]  A. Kastrati,et al.  Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. , 2000, Journal of the American College of Cardiology.

[153]  G. Morahan,et al.  Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit , 2000, Genes and Immunity.

[154]  K. Tokunaga,et al.  New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus , 2000, Genes and Immunity.

[155]  A. Woodcock,et al.  The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma , 2000, Genes and Immunity.

[156]  F. Pociot,et al.  Characterization of new polymorphisms in the 5′UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level , 2000, Genes and Immunity.

[157]  Y. Aizawa,et al.  Contribution of TNF-α and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation , 2000, Bone Marrow Transplantation.

[158]  M. Muto,et al.  Lack of Association Between Promoter Polymorphism of the Tumor Necrosis Factor-α Gene and Psoriatic Arthritis in Japanese Patients , 2000 .

[159]  S. Marshall,et al.  THE IMPACT OF RECIPIENT CYTOKINE GENOTYPE ON ACUTE REJECTION AFTER RENAL TRANSPLANTATION , 2000, Transplantation.

[160]  T. Klockgether,et al.  No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′flanking region of the interleukin-6 gene in patients with multiple sclerosis , 2000, Neuroscience Letters.

[161]  K. Fearon,et al.  A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer , 2000, British Journal of Cancer.

[162]  M. Zago,et al.  Gene polymorphisms in the TNF locus and the risk of myocardial infarction. , 2000, Thrombosis research.

[163]  T. Hayakawa,et al.  Tumor necrosis factor-β gene Nco I polymorphism decreases insulin resistance in Japanese men , 2000 .

[164]  C. Salvarani,et al.  Interleukin-1 cluster and tumor necrosis factor-α gene polymorphisms in polymyalgia rheumatica , 2000 .

[165]  K. Tokunaga,et al.  Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. , 2000, Tissue antigens.

[166]  S. Perrotta,et al.  Osteoporosis in β‐thalassaemia major patients: analysis of the genetic background , 2000, British journal of haematology.

[167]  S. Socransky,et al.  Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. , 2000, Journal of clinical periodontology.

[168]  I. J. McKay,et al.  Polymorphisms in the IL-1A Gene are Correlated with Levels of Interleukin-1α Protein in Gingival Crevicular Fluid of Teeth with Severe Periodontal Disease , 2000, Journal of dental research.

[169]  J. Epplen,et al.  The IL‐10 gene is not involved in the predisposition to inflammatory bowel disease , 2000, Electrophoresis.

[170]  F. Breedveld,et al.  Are differences in interleukin 10 production associated with joint damage? , 2000, Rheumatology.

[171]  N. Camp,et al.  An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. , 2000, The Journal of infectious diseases.

[172]  N C Andreasen,et al.  Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia , 2000, Molecular Psychiatry.

[173]  C. Bouchard,et al.  Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[174]  G. Rebeck.  Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease , 2000, Neuroscience Letters.

[175]  Wei Zhang,et al.  Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. , 2000, The Journal of investigative dermatology.

[176]  M. Malaise,et al.  Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. , 2000, The European respiratory journal.

[177]  P. Miossec,et al.  IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. , 2000, Rheumatology.

[178]  S. Steinberg,et al.  An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. , 2000, Blood.

[179]  F. Wiklund,et al.  Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[180]  R. González-Sarmiento,et al.  Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. , 2000, Alcoholism, clinical and experimental research.

[181]  A. Patiño-García,et al.  Analysis of the human tumour necrosis factor-alpha (TNFα) gene promoter polymorphisms in children with bone cancer , 2000, Journal of medical genetics.

[182]  K. Morgan,et al.  A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. , 2000, Chest.

[183]  A. Dignass,et al.  Genetic factors determine extent of bone loss in inflammatory bowel disease. , 2000, Gastroenterology.

[184]  G. Comi,et al.  Lack of association betweenIL-1A and IL-1Bpromoter polymorphisms and multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[185]  P. Lakatos,et al.  Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. , 2000, Bone.

[186]  A. Demaine,et al.  A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[187]  A. Goris,et al.  High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease , 2000, Genes and Immunity.

[188]  Paul Wordsworth,et al.  Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis , 2000, Genes and Immunity.

[189]  D. Lacaille,et al.  Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis , 2000, The Lancet.

[190]  Y. Ouchi,et al.  Neither IL-1 β, IL-1 receptor antagonist, nor TNF- α polymorphisms are associated with susceptibility to COPD , 2000 .

[191]  W. Weimar,et al.  Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[192]  J. J. Taylor,et al.  Association of interleukin-1 gene polymorphisms with early-onset periodontitis. , 2000, Journal of clinical periodontology.

[193]  N. Nakamura,et al.  Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies. , 2000, The Journal of clinical endocrinology and metabolism.

[194]  E. Sampaio,et al.  Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. , 2000, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[195]  J. Colmenero,et al.  TNFA promoter polymorphism and susceptibility to brucellosis , 2000, Clinical and experimental immunology.

[196]  G. Annoni,et al.  Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk , 2000, Annals of neurology.

[197]  R. Westendorp,et al.  High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[198]  J. Rotter,et al.  Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. , 2000, Human molecular genetics.

[199]  C. Orosz,et al.  EVIDENCE FOR A GENETIC PREDISPOSITION TOWARDS ACUTE REJECTION AFTER KIDNEY AND SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION1 , 2000, Transplantation.

[200]  W. Oertel,et al.  Association of an interleukin 1α polymorphism with Alzheimer’s disease , 2000, Neurology.

[201]  N. Wake,et al.  Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. , 2000, Cancer research.

[202]  C. Chi,et al.  Tumor necrosis factor gene polymorphism and septic shock in surgical infection , 2000, Critical care medicine.

[203]  J. Chan,et al.  Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. , 2000, Metabolism: clinical and experimental.

[204]  H. Inoko,et al.  Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis. , 2000, Tissue antigens.

[205]  I. D. Johnston,et al.  Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. , 2000, American journal of respiratory and critical care medicine.

[206]  K. Shu,et al.  Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. , 2000, Kidney international.

[207]  W. Thomson,et al.  Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. , 2000, Arthritis and rheumatism.

[208]  P. Heasman,et al.  Dinucleotide repeat polymorphism in the interleukin-10 gene promoter (IL-10.G) and genetic susceptibility to early-onset periodontal disease , 2000, Genes and Immunity.

[209]  K. Tokunaga,et al.  Independent contribution of HLA-DRB1 and TNFα promoter polymorphisms to the susceptibility to Crohn’s disease , 2000, Genes and Immunity.

[210]  S. Taketani,et al.  Analysis of the candidate genes responsible for non-syndromic cleft lip and palate in Japanese people. , 2000, Clinical science.

[211]  R. Kaslow,et al.  Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection , 2000, Genes and Immunity.

[212]  Yoshiji Yamada,et al.  Association of a Leu10→Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis , 2000, Mechanisms of Ageing and Development.

[213]  B. Weinshenker,et al.  Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis , 2000, Journal of Neuroimmunology.

[214]  M. Haider,et al.  Interleukin-4 Gene Promoter Polymorphism [C590T] and Asthma in Kuwaiti Arabs , 2000, International Archives of Allergy and Immunology.

[215]  S. Jimenez,et al.  Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies , 2000, Clinical and experimental immunology.

[216]  J. Spinelli,et al.  Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. , 2000, The Journal of allergy and clinical immunology.

[217]  U. Wahn,et al.  An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). , 2000, The Journal of allergy and clinical immunology.

[218]  Daniel L. Koller,et al.  Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus. , 2000, Bone.

[219]  M. Yokota,et al.  Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. , 2000, Circulation.

[220]  W. Sugiura,et al.  Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype , 2000, Journal of Virology.

[221]  P. Galle,et al.  Different Transcriptional Activity and In Vitro TNF-α Production in Psoriasis Patients Carrying the TNF-α 238A Promoter Polymorphism , 2000 .

[222]  E. G. de la Concha,et al.  Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[223]  T. Bednarczuk,et al.  A polymorphism of the 5′ flanking region of tumour necrosis factor α gene is associated with thyroid‐associated ophthalmopathy in Japanese , 2000, Clinical endocrinology.

[224]  S. Sawcer,et al.  Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis , 2000, Journal of Neuroimmunology.

[225]  N. Brooks,et al.  Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[226]  Pille Harrison,et al.  The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. , 2000, Journal of hepatology.

[227]  J. Martín,et al.  Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis. , 2000, The Journal of rheumatology.

[228]  A. Balsa,et al.  IL-6 promoter polymorphisms in rheumatoid arthritis , 2000, Genes and Immunity.

[229]  R. Bois,et al.  Identification of four novel interleukin-13 gene polymorphisms , 2000, Genes and Immunity.

[230]  S. DeKosky,et al.  Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease , 2000, Human Genetics.

[231]  L. Iacoviello,et al.  Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. , 2000, Circulation.

[232]  S. Walker,et al.  Genetic polymorphisms of the IL-1α and IL-1β genes in African-American LJP patients and an African-American control population , 2000 .

[233]  P. Paré,et al.  Polymorphisms of the IL-4, TNF- α , and Fc α RI β Genes and the Risk of Allergic Disorders in At-risk Infants , 2000 .

[234]  A. Blanco‐quirós,et al.  Increased TNFA*2, but not TNFB*1, allele frequency in Spanish atopic patients. , 2000, Journal of investigational allergology & clinical immunology.

[235]  M. Ishii,et al.  Interleukin 4 receptor α chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan , 2000, The British journal of dermatology.

[236]  E. Trabetti,et al.  Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. , 2000, Chest.

[237]  A. Kimura,et al.  Susceptible locus for obese type 2 diabetes mellitus in the 5'-flanking region of the tumor necrosis factor-alpha gene. , 2000, Tissue antigens.

[238]  E. G. de la Concha,et al.  Celiac disease and TNF promoter polymorphisms. , 2000, Human immunology.

[239]  K. Ihara,et al.  Childhood Atopic Asthma: Positive Association with a Polymorphism of IL-4 Receptor α Gene but Not with That of IL-4 Promoter or Fc ε Receptor I β Gene , 2000, Experimental and Clinical Immunogenetics.

[240]  F. Arnett,et al.  Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association. , 2000, Arthritis and rheumatism.

[241]  S. Maeyama,et al.  Genetic polymorphisms of interleukin-1β in association with the development of alcoholic liver disease in Japanese patients , 2000, American Journal of Gastroenterology.

[242]  J. Bell,et al.  Cytokine gene polymorphisms in autoimmune thyroid disease. , 2000, The Journal of clinical endocrinology and metabolism.

[243]  M. Sudomoina,et al.  Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. , 2000, Journal of neurovirology.

[244]  I. Mizuta,et al.  Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease , 2000, Neuroscience Letters.

[245]  P. Hayes,et al.  The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. , 2000, Transplantation.

[246]  F. Jessen,et al.  Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population , 2000, Neuroscience Letters.

[247]  P. Rieckmann,et al.  Genetic variation at position –1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis , 2000, Journal of Neuroimmunology.

[248]  M. Björkholm,et al.  Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma , 2000 .

[249]  K. Tokunaga,et al.  Tumor necrosis factor α 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis , 2000 .

[250]  Xing-li Wang,et al.  Tumour necrosis factor α G−308→A polymorphism and risk for coronary artery disease , 2000 .

[251]  T. Hansen,et al.  The -238 and -308 G-->A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. , 2000, The Journal of clinical endocrinology and metabolism.

[252]  E. G. de la Concha,et al.  Tumor necrosis factor genomic polymorphism in Spanish IGA deficiency patients. , 2000, Tissue antigens.

[253]  D. Sitara,et al.  Characterization of a rare sty I polymorphism in exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[254]  J. Isaacs,et al.  No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis , 2000, The British journal of ophthalmology.

[255]  Marco Lorenzi,et al.  Transforming Growth Factor‐β1 Gene Polymorphism, Bone Turnover, and Bone Mass in Italian Postmenopausal Women , 2000 .

[256]  G. Lucotte,et al.  TNF-α polymorphisms in multiple sclerosis: no association with −238 and −308 promoter alleles, but the microsatellite allele all is associated with the disease in French patients , 2000, Multiple sclerosis.

[257]  J. Grove,et al.  Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease , 2000, Gut.

[258]  Hiromitsu Nabeta,et al.  Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients , 2000, Annals of the rheumatic diseases.

[259]  Jane Worthington,et al.  Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas , 2000, The British journal of dermatology.

[260]  L. Murray,et al.  Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.

[261]  Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism , 2000, Annals of neurology.

[262]  D. Papanicolaou,et al.  Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[263]  F. Stüber,et al.  Pilot Study Assessing TNF Gene Polymorphism as a Prognostic Marker for Disease Progression in Neonates with Sepsis , 2000, Infection.

[264]  E. Eriksen,et al.  Osteoporotic Fractures Are Associated with an 86‐Base Pair Repeat Polymorphism in the Interleukin‐1‐Receptor Antagonist Gene But Not with Polymorphisms in the Interleukin‐1β Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[265]  S. Weiland,et al.  A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. , 2000, The Journal of allergy and clinical immunology.

[266]  S. Wakelin,et al.  Association of TNFA gene polymorphism at position –308 with susceptibility to irritant contact dermatitis , 2000, Immunogenetics.

[267]  N. Pride,et al.  Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease , 2000 .

[268]  K. Ihara,et al.  Novel Polymorphism in the Coding Region of the IL-13 Receptor Alpha’ Gene: Association Study with Atopic Asthma in the Japanese Population , 2000, Experimental and Clinical Immunogenetics.

[269]  A. Demaine,et al.  A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[270]  T. Horie,et al.  Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. , 2000, Internal medicine.

[271]  G. Armitage,et al.  Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. , 2000, Journal of periodontology.

[272]  Y. Zhou,et al.  Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. , 2000, The Journal of rheumatology.

[273]  K. Ikeda,et al.  Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. , 2000, Arthritis and rheumatism.

[274]  F. Pociot,et al.  Linkage disequilibrium testing of four interleukin-1 gene-cluster polymorphisms in Danish multiplex families with insulin-dependent diabetes mellitus. , 2000, Cytokine.

[275]  S. Witkin,et al.  Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. , 2000, American journal of obstetrics and gynecology.

[276]  J. G. Park,et al.  Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[277]  V. Pravica,et al.  Rare polymorphisms in the promoter regions of the human interleukin-12 p35 and interleukin-12 p40 subunit genes. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[278]  G. Duff,et al.  Interleukin-1 genetic association with periodontitis in clinical practice. , 2000, Journal of periodontology.

[279]  D. Middleton,et al.  Genetic polymorphism of IL-12 p40 gene in immune-mediated disease , 2000, Genes and Immunity.

[280]  K. Sullivan,et al.  A TNFR2 3′ flanking region polymorphism in systemic lupus erythematosus , 2000, Genes and Immunity.

[281]  S. D'alfonso,et al.  New polymorphisms in the IL-10 promoter region , 2000, Genes and Immunity.

[282]  A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a , 2000, Genes and Immunity.

[283]  D. Sitara,et al.  A Bsr BI polymorphism in exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene , 2000, Genes and Immunity.

[284]  H. Obayashi,et al.  Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. , 2000, Annals of neurology.

[285]  W. Ollier,et al.  Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. , 2000, Tissue antigens.

[286]  L. Rand,et al.  Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma. , 2000, Human genetics.

[287]  M. V. van Krugten,et al.  TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[288]  T. Sasazuki,et al.  Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. , 2000, Tissue antigens.

[289]  N. Pride,et al.  Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. , 2000, The European respiratory journal.

[290]  S. Paul,et al.  Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. , 2000, Neurology.

[291]  T. Hayakawa,et al.  Tumor necrosis factor-beta gene NcoI polymorphism decreases insulin resistance in Japanese men. , 2000, Metabolism: clinical and experimental.

[292]  Y. Ouchi,et al.  Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. , 2000, Respiratory medicine.

[293]  I. Mizuta,et al.  Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease. , 2000, Neuroscience letters.

[294]  Y. Aizawa,et al.  Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. , 2000, Bone marrow transplantation.

[295]  M. Björkholm,et al.  Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. , 2000, British journal of haematology.

[296]  A. Vasku,et al.  Polymorphisms in inflammation genes (angiotensinogen, TAP1 and TNF-beta) in psoriasis. , 2000, Archives of dermatological research.

[297]  M. Chan-yeung,et al.  Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. , 2000, American journal of respiratory and critical care medicine.

[298]  X. L. Wang,et al.  Tumour necrosis factor alpha G-308-->A polymorphism and risk for coronary artery disease. , 2000, Clinical science.

[299]  K. Tokunaga,et al.  Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[300]  S. Gapstur,et al.  Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[301]  T. Bednarczuk,et al.  A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. , 2000, Clinical endocrinology.

[302]  P. Galle,et al.  Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. , 2000, The Journal of investigative dermatology.

[303]  A. Iwamoto,et al.  A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene , 2000, Genes and Immunity.

[304]  L. Tiret,et al.  Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. , 2000, Journal of the American College of Cardiology.

[305]  R. Krüger,et al.  Genetic analysis of immunomodulating factors in sporadic Parkinson's disease , 2000, Journal of Neural Transmission.

[306]  J. Lacki,et al.  TNF-α gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis , 2000, Rheumatology International.

[307]  J. Dewar,et al.  Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals , 2000, Immunogenetics.

[308]  S. Schreiber,et al.  Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease , 2000, Immunogenetics.

[309]  D. Sitara,et al.  Identification of novel single nucleotide polymorphisms in intron 1B and exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene , 1999, Genes and Immunity.

[310]  M. Seldin,et al.  Welcome to ‘Genes and Immunity’ , 1999, Genes and Immunity.

[311]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.

[312]  J. Bidwell,et al.  Human cytokine gene nucleotide sequence alignments, 1998. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[313]  S. Dower,et al.  The interleukin-1 receptor and post-receptor events , 1989 .

[314]  Moses Rodriguez,et al.  Encephalomyelitis Virus Infection Intracranial Theiler ' s Murine Susceptible Mouse Strain following Early Viral Clearance and Protection in a Gamma Interferon Is Critical for Neuronal , 2003 .